Author:
Monnier A.,Malbranche C.,Fagnoni P.,Serge Aho L.,Guerard P.,Sgro C.,Guignard M.-H.,Croisier-Bertin D.,Chavanet P.,Chrétien M.-L.,Caillot D.,Boulin M.
Subject
Pharmaceutical Science,Pharmacology
Reference27 articles.
1. World Health Organization. Marketing authorization of pharmaceutical products with special reference to multisource (generic) products: a manual for a drug regulatory authority. 1998. www.apps.who.int/prequal/info_general/documents/WHO_DMP_RGS_98_5_R.pdf (last consultation 20 April 2013).
2. Generic vancomycin products fail in vivo despite being pharmaceutical equivalents of the innovator;Vesga;Antimicrobiol Agents Chemother,2010
3. Efficacy and quality of antibacterial generic products approved for human use: a systematic review;Tattevin;Clin Infect Dis,2013
4. Comparison of six generic vancomycin products for treatment of methicillin-resistant Staphylococcus aureus experimental endocarditis in rabbits;Tattevin;Antimicrobiol Agents Chemother,2013
5. The World Health Organization (WHO) classification of the myeloid neoplasms;Vardiman;Blood,2002
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献